Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ladan Fazli

Showing results (101-110 of 270) with videos related to

Pageof 27
Sort By:
International Journal of Cancer|August 21, 2014
The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumorsNing Xie, Helen Cheng, Dong Lin, et al.
BJU International|September 14, 2007
A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imagingBoris A Hadaschik, Peter C Black, Jason C Sea, et al.
The Prostate|October 25, 2016
Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer ProgressionTakashi Dejima, Kenjiro Imada, Ario Takeuchi, et al.
Clinical & Experimental Metastasis|February 11, 2014
A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human boneParisa Hesami, Boris M Holzapfel, Anna Taubenberger, et al.
The Prostate|February 8, 2013
Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancerMarie-Odile Guimond, Marie-Claude Battista, Fatemeh Nikjouitavabi, et al.
Molecular Cancer Therapeutics|January 11, 2011
Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivoChristian Thomas, Amina Zoubeidi, Hidetoshi Kuruma, et al.
Anti-Cancer Drugs|April 7, 2012
A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancerAlain Gulenga Musende, Andy Eberding, Catherine A Wood, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|October 22, 2014
Multi-parametric 3D quantitative ultrasound vibro-elastography imaging for detecting palpable prostate tumorsOmid Mohareri, Angelica Ruszkowski, Julio Lobo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2015
siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate CancerYoshiaki Yamamoto, Paulo J C Lin, Eliana Beraldi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2019
Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 functionBin Gui, Fu Gui, Tomoaki Takai, et al.
Pageof 27

Showing results (101-110 of 270) with videos related to

Sort By:
Pageof 27
International Journal of Cancer|August 21, 2014
The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumorsNing Xie, Helen Cheng, Dong Lin, et al.
BJU International|September 14, 2007
A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imagingBoris A Hadaschik, Peter C Black, Jason C Sea, et al.
The Prostate|October 25, 2016
Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer ProgressionTakashi Dejima, Kenjiro Imada, Ario Takeuchi, et al.
Clinical & Experimental Metastasis|February 11, 2014
A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human boneParisa Hesami, Boris M Holzapfel, Anna Taubenberger, et al.
The Prostate|February 8, 2013
Expression and role of the angiotensin II AT2 receptor in human prostate tissue: in search of a new therapeutic option for prostate cancerMarie-Odile Guimond, Marie-Claude Battista, Fatemeh Nikjouitavabi, et al.
Molecular Cancer Therapeutics|January 11, 2011
Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivoChristian Thomas, Amina Zoubeidi, Hidetoshi Kuruma, et al.
Anti-Cancer Drugs|April 7, 2012
A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancerAlain Gulenga Musende, Andy Eberding, Catherine A Wood, et al.
Medical Image Computing and Computer-Assisted Intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention|October 22, 2014
Multi-parametric 3D quantitative ultrasound vibro-elastography imaging for detecting palpable prostate tumorsOmid Mohareri, Angelica Ruszkowski, Julio Lobo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2015
siRNA Lipid Nanoparticle Potently Silences Clusterin and Delays Progression When Combined with Androgen Receptor Cotargeting in Enzalutamide-Resistant Prostate CancerYoshiaki Yamamoto, Paulo J C Lin, Eliana Beraldi, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2019
Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 functionBin Gui, Fu Gui, Tomoaki Takai, et al.
Pageof 27